Impact of clonal haematopoiesis with indeterminate potential mutations on transcription in single-cells (WP1)
Josep Carreras Leukaemia Research Institute, Spain
Shubhra A. Bhattacharya
Marcus Buschbeck, Roberto Malinverni
Find out moreIndividual ESR projects
Our 12 Early Stage Researchers (ESRs) carry out individual research projects at their host institutions under the supervision of our network members. Each project belongs to one of our three dedicated research work packages (WPs) to address our scientific objectives.
The ESRs will undertake secondments to institutions belonging to other sectors and environments during the development of the project, and all of them are enrolled in the PhD programme of one of the participating organisations of the network.
Dissect haematopoietic stem/progenitor cells-bone marrow niche interaction on a single cell level in low risk myelodysplastic syndromes (WP1)
Erasmus Medical Center, The Netherlands
Stephani Schmitz
Rebekka Schneider, Hélène Gleitz
Find out more
Dissecting the cellular crosstalk between the bone marrow microenvironment and hematopoietic stem/progenitor cells in clonal hematopoiesis of indeterminate potential, myelodysplastic syndromes and secondary acute myeloid leukaemia (WP1)
Klinikum rechts der Isar der TU München, Germany
Anna Navarro i Figueredo
Katharina Götze
Find out more
Phenotypic heterogeneity of myelodysplastic cells and influence of epigenetic therapies (WP1)
Institut national de la sante et de la recherche medicale, France
Nuria Álvarez Pizarroso
Alexandre Puissant, Raphael Itzykson
Find out more
Understanding and reverting the epigenetic reprogramming of bone marrow stroma cells in myelodysplastic syndromes (WP2)
Josep Carreras Leukaemia Research Institute, Spain
Eve Dias
Marcus Buschbeck, René Winkler
Find out more
Targeted inhibition of the NUP98-NSD1 and NUP98-KDM5A fusion oncogenes in myelodysplastic syndromes and acute myeloid leukaemia models by NSD1 and KDM5A inhibitors (WP2)
Josep Carreras Leukaemia Research Institute, Spain
James Heald
Manel Esteller, María Berdasco
Find out more
Functional identification of effectors of fusion proteins that drive secondary-type acute myeloid leukaemia (WP2)
Veterinärmedizinische Universität Wien, Austria
Ecem Kirkiz
Florian Grebien
Find out more
DNA methylation as determinant of myelodysplastic syndromes treatment with hypomethylating agents (WP2)
Università degli Studi di Firenze, Italy
Sven De Pourcq
Valeria Santini
Find out more
Exploiting 3D organotypic niche models to dissect the cellular crosstalk between niche and haematopoietic stem/progenitor cells in human myelodysplastic syndromes (WP3)
Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Germany
Hind Medyouf
Find out more
Enhancing the informative value of bulk bone marrow RNA-seq by inferring cell-type contributions (WP3)
MLL Munich Leukemia Laboratory, Germany
Maki Sakuma
Torsten Haferlach, Wencke Walter
Find out more
Development of pre-clinical patient-derived xenograft models of myelodysplastic syndromes (WP3)
University of Bergen, Norway
Ângela Sofia Gerós Mesquita
Emmet McCormack
Find out more
Development of methods for the functional analysis of single-cell RNA-seq data (WP3)
BioBam Bioinformatics, Spain
Priyansh Srivastava
Ana Conesa, Stefan Götz
Find out more